surmount-1 tirzepatide trial weight loss non-diabetic SURMOUNT 1 // Three-Year Obesty & Diabetes Prevention Outcomes Tirzepatide after intensive lifestyle intervention

Hence, in a world where appetite and the desire to eat are reduced, there is the potential for lost sales of fast foods, snacks and sugary drinks

As powerful anti-obesity drugs become more widely available, companies are repositioning themselves with new products and services.

It can be unsettling to notice a heart that feels like it's racing, fluttering, or pounding when starting a new

Do weight loss injections cause fatigue

French researchers have developed a new drug delivery system that could cut the dosing schedule for type 2 diabetes and weight control drug semaglutide to just once a month, according researchpresented at this year's annual meeting of the European Association for the Study of Diabetes (EASD)."Glucagon-like peptide-1 agonist (GLP-1) drugs have transformed type 2 diabetes care, but weekly injections can be burdensome for patients, said lead author, Dr Claire Mgret from Adocia, Lyon, France, the